0000899243-20-029938.txt : 20201030
0000899243-20-029938.hdr.sgml : 20201030
20201030165510
ACCESSION NUMBER: 0000899243-20-029938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201029
FILED AS OF DATE: 20201030
DATE AS OF CHANGE: 20201030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sinha Uma
CENTRAL INDEX KEY: 0001742587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 201277997
MAIL ADDRESS:
STREET 1: C/O EIDOS THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-29
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001742587
Sinha Uma
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2000
SAN FRANCISCO
CA
94104
1
1
0
0
Chief Scientific Officer
Common Stock
2020-10-29
4
S
0
1300
71.9024
D
325225
D
Common Stock
2020-10-29
4
S
0
3700
72.6016
D
321525
D
This transaction was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 13, 2020.
Represents the weighted average sale price of the shares sold ranging from $71.26 to $72.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
Represents the weighted average sale price of the shares sold ranging from $72.29 to $72.94 per share.
/s/ Franco Valle, Attorney-in-Fact
2020-10-30